Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-19-003721
Filing Date
2019-01-28
Accepted
2019-01-28 17:48:50
Documents
1
Period of Report
2019-01-24

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3205
  Complete submission text file 0001104659-19-003721.txt   4575
Mailing Address 1717 ARCH STREET 35TH FLOOR PHILADELPHIA PA 19103
Business Address
COWAN GREGORY L (Reporting) CIK: 0001205025 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38709 | Film No.: 19546647

Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
Osmotica Pharmaceuticals plc (Issuer) CIK: 0001739426 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations